Elicio Therapeutics Inc.

NASDAQ: ELTX · Real-Time Price · USD
11.80
1.96 (19.92%)
At close: Aug 18, 2025, 1:44 PM

Elicio Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.2 -1.2 -0.65 -0.71
PEG Ratio
0.03 0.05 0.01 -0.00
PS Ratio
n/a n/a n/a 0.67
PB Ratio
-5.5 3.71 2.05 -0.25
P/FCF Ratio
-1.68 -1.29 -0.8 -0.77
P/OCF Ratio
-1.68 -1.29 -0.82 -0.79
OCF/S Ratio
n/a n/a n/a -0.85
Debt / Equity Ratio
-2.3 0.61 0.84 -0.16
Quick Ratio
1.80 1.67 0.95 0.54
Current Ratio
1.80 1.67 1.56 0.55
Asset Turnover
n/a n/a n/a 1.91
Interest Coverage
-98.87 -33.75 -6.6 -29.07
Return on Equity
4.59 -3.09 -3.16 0.35
Return on Assets
-1.84 -1.3 -1.24 -1.78
Return on Invested Capital
-2.56 -1.86 -1.38 -3.4
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a 0.96
Net Profit Margin
n/a n/a n/a -0.93
Pretax Profit Margin
n/a n/a n/a -0.93
Operating Profit Margin
n/a n/a n/a -0.9
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a -1.83